Toll Free: 1-888-928-9744

Mymetics Corporation - Product Pipeline Review - 2014

Published: Apr, 2014 | Pages: 31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Mymetics Corporation - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Mymetics Corporation - Product Pipeline Review - 2014', provides an overview of the Mymetics Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Mymetics Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Mymetics Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Mymetics Corporation's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Mymetics Corporation's pipeline products

Reasons to buy

- Evaluate Mymetics Corporation's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Mymetics Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Mymetics Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Mymetics Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Mymetics Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Mymetics Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Mymetics Corporation Snapshot 4
Mymetics Corporation Overview 4
Key Information 4
Key Facts 4
Mymetics Corporation - Research and Development Overview 5
Key Therapeutic Areas 5
Mymetics Corporation - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Out-Licensed Products 9
Out-Licensed Products/Combination Treatment Modalities 10
Mymetics Corporation - Pipeline Products Glance 11
Mymetics Corporation - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Mymetics Corporation - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Mymetics Corporation - Drug Profiles 13
MYM-V101 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
PEV-3 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Vaccine for Influenza 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Vaccine for Herpes Simplex Infections 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Mymetics Corporation - Pipeline Analysis 19
Mymetics Corporation - Pipeline Products by Target 19
Mymetics Corporation - Pipeline Products by Route of Administration 20
Mymetics Corporation - Pipeline Products by Molecule Type 21
Mymetics Corporation - Recent Pipeline Updates 22
Mymetics Corporation - Dormant Projects 24
Mymetics Corporation - Company Statement 25
Mymetics Corporation - Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31
List of Tables
Mymetics Corporation, Key Information 4
Mymetics Corporation, Key Facts 4
Mymetics Corporation - Pipeline by Indication, 2014 6
Mymetics Corporation - Pipeline by Stage of Development, 2014 7
Mymetics Corporation - Monotherapy Products in Pipeline, 2014 8
Mymetics Corporation - Out-Licensed Products in Pipeline, 2014 9
Mymetics Corporation - Out-Licensed Products/ Combination Treatment Modalities, 2014 10
Mymetics Corporation - Phase I, 2014 11
Mymetics Corporation - Preclinical, 2014 12
Mymetics Corporation - Pipeline by Target, 2014 19
Mymetics Corporation - Pipeline by Route of Administration, 2014 20
Mymetics Corporation - Pipeline by Molecule Type, 2014 21
Mymetics Corporation - Recent Pipeline Updates, 2014 22
Mymetics Corporation - Dormant Developmental Projects,2014 24
Mymetics Corporation, Subsidiaries 29 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify